← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$6K

Shares

194

Price

$31

Filed

Dec 5

Insider

Name

Allan Jonathan

Title

GENERAL COUNSEL & CORP SEC

CIK

0001966716

Roles

Officer

Transaction Details

Transaction Date

2025-12-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,594

Footnotes

The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $31.19 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3, 4, 6, and 7 of this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.23 to $31.505 per share, inclusive. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.93 to $31.69 per share, inclusive. | This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.58 to $31.57 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.59 to $31.97 per share, inclusive. | Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. | Half the award vested on December 3, 2024 and the remainder vested or vests on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date.

Filing Info

Accession No.

0001966716-25-000008

Form Type

4

Issuer CIK

0001623526

Allan Jonathan's History

Date Ticker Type Value
2026-03-20 STOK $292K
2026-03-20 STOK $21K
2025-12-08 STOK $41K
2025-12-08 STOK $87K
2025-12-05 STOK $31K
2025-12-05 STOK $169K
2025-12-05 STOK $74K
2025-12-04 STOK $25K
2025-12-04 STOK $6K
2025-12-03 STOK $27K

Other Insiders at STOK (90d)

Insider Bought Sold Last
Ticho Barry
CHIEF MEDICAL OFFICER
$60K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$313K 2026-03-20